All PlansCoverageHigh impact
Healthfirst Lab Reimbursement Policy Updates
Healthfirst·Endocrinology, OB-GYN, Internal Medicine +7 more·Provider Update
Effective date
Aug 1, 2026
We identified it
Jul 9, 2026
Summary
Healthfirst has updated its Thyroid Disease Testing Reimbursement Policy (PO-RE-002v6) effective August 1, 2026, establishing new coverage criteria and testing frequencies for TSH, free/total T4, T3, and thyroid antibody testing. The policy specifies which clinical indications meet coverage (e.g., symptoms of hypo/hyperthyroidism, pregnancy history, immunosuppressive therapy) and denies coverage for non-indicated screening and certain tests (TBG, TRH, reverse T3, T3 uptake). Billing teams must ensure claims align with the documented clinical indication and approved testing frequency to avoid denials.
Action Required
By July 1, 2026: Billing team must implement policy controls in billing software to enforce Healthfirst thyroid testing coverage criteria. (1) Create verification checklist requiring providers to document clinical indication at time of order (e.g., hypothyroid symptoms, pregnancy loss history, immune reconstitution therapy, medication-induced thyrotoxicosis, chronic urticaria, type 1 diabetes, or thyroid nodule). (2) Configure system to flag denials for tests ordered without qualifying indication or exceeding frequency limits (e.g., TSH more than once every 6 weeks for symptomatic patients, annual screening for type 1 diabetes). (3) Train billing staff to deny reflex testing (fT4, T3, antibodies) that lacks abnormal TSH result documentation. (4) Confirm lab partners are using trimester-specific normal ranges for pregnant patients (per Note 3). (5) Establish denial appeal process for borderline/complex cases. (6) Update encounter templates and order entry screens in EMR to prompt for required clinical indication. Non-compliant claims will be denied by Healthfirst; document all denials by indication type to identify workflow gaps. Reference full policy at HFproviders.org/Reimbursement-Policies.